A 2026 systematic review and meta-analysis found oral doxycycline performed similarly to azithromycin for acne vulgaris. Acne vulgaris means common acne with pimples, blackheads, and inflamed red bumps. The review pooled randomized controlled trials of doxycycline against other therapies following PRISMA guidelines. Its main measures were treatment success, inflammatory lesion change, and Global Acne Grading System scores, plus reported adverse events.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How well did doxycycline clear acne?
- What side effects need attention?
- Who is most affected, and how solid is the evidence?
- How do dermatologists recommend using it?
How well did doxycycline clear acne?
Treatment success did not differ significantly between doxycycline and azithromycin. The odds ratio was 1.28, with wide confidence limits and moderate variation across trials, as reported in the review archived by the U.S. National Library of Medicine/PMC pooled treatment-success analysis. Reduction in inflammatory lesions also showed no significant difference from controls.
The mean difference was minus 0.71 lesions, with very wide confidence limits and very high variation. In plain terms, some trials favored doxycycline and others favored controls. Scores on the Global Acne Grading System told a different story. Control treatments scored significantly better, with a mean difference of 1.76 points. That split shows results depend on which outcome measure is used.
What side effects need attention?
Stomach and gut effects were the clearest drawback. One included trial found gastrointestinal disturbances in 46 percent of doxycycline users versus 20 percent for azithromycin.
Skin reactions were also common and practical for daily life. Photosensitivity affected 4.8 to 17 percent, plus scaling, redness, and stinging or burning. Those effects match the nausea, vomiting, diarrhea, rash, and photosensitivity described in the FDA doxycycline label FDA prescribing information.
Who is most affected, and how solid is the evidence?
The findings matter most for adolescents and young adults with moderate-to-severe acne. For them, oral doxycycline remains a common systemic choice when topical treatment alone falls short. Confidence in the pooled numbers is limited.
The trial base was small and heterogeneity reached 97 percent for lesion counts. High heterogeneity means trials differed too much for one average to fit everyone. Readers should treat doxycycline as broadly similar to alternatives, not proven better or worse. Personal response, tolerability, cost, and sun exposure often drive the choice.
How do dermatologists recommend using it?
The 2024 American Academy of Dermatology guidelines strongly recommend doxycycline based on moderate-certainty evidence, usually with benzoyl peroxide or a retinoid. The guidance favors limited courses rather than open-ended use, according to the guideline published in the Journal of the American Academy of Dermatology AAD acne guideline. Ask a clinician about these practical steps:.
- Combine doxycycline with benzoyl peroxide or a topical retinoid when advised
- Use daily sun protection because sunlight can burn treated skin faster
- Take each dose with ample water and food as directed
- Review course length and follow-up before refills run out